Stephens Inc. AR Has $2.17 Million Position in The Cigna Group (NYSE:CI)

Stephens Inc. AR trimmed its holdings in The Cigna Group (NYSE:CI - Free Report) by 42.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,857 shares of the health services provider's stock after selling 5,728 shares during the quarter. Stephens Inc. AR's holdings in The Cigna Group were worth $2,170,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CI. AMF Tjanstepension AB grew its holdings in The Cigna Group by 18.6% in the 3rd quarter. AMF Tjanstepension AB now owns 73,600 shares of the health services provider's stock worth $25,511,000 after buying an additional 11,550 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in The Cigna Group by 5,543.6% during the 3rd quarter. Exchange Traded Concepts LLC now owns 5,700 shares of the health services provider's stock valued at $1,975,000 after purchasing an additional 5,599 shares in the last quarter. Redhawk Wealth Advisors Inc. boosted its stake in The Cigna Group by 1.8% during the 3rd quarter. Redhawk Wealth Advisors Inc. now owns 2,234 shares of the health services provider's stock valued at $774,000 after purchasing an additional 39 shares in the last quarter. Paladin Wealth LLC bought a new position in The Cigna Group during the 3rd quarter valued at $149,000. Finally, CX Institutional boosted its stake in The Cigna Group by 115.4% during the 3rd quarter. CX Institutional now owns 33,315 shares of the health services provider's stock valued at $11,542,000 after purchasing an additional 17,852 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

The Cigna Group Stock Down 2.6 %

Shares of CI traded down $7.70 during mid-day trading on Friday, reaching $292.12. The company's stock had a trading volume of 1,579,577 shares, compared to its average volume of 1,953,796. The business has a fifty day moving average of $286.46 and a 200 day moving average of $321.09. The company has a market cap of $81.25 billion, a price-to-earnings ratio of 23.87, a price-to-earnings-growth ratio of 0.94 and a beta of 0.54. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the previous year, the business earned $6.79 EPS. As a group, analysts forecast that The Cigna Group will post 29.8 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.07%. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date of this dividend is Wednesday, March 5th. The Cigna Group's dividend payout ratio (DPR) is currently 45.75%.

Analysts Set New Price Targets

CI has been the subject of a number of research reports. Morgan Stanley decreased their price target on The Cigna Group from $403.00 to $379.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Cantor Fitzgerald decreased their price target on The Cigna Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Wells Fargo & Company cut their price objective on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a research report on Tuesday, February 4th. Truist Financial cut their price objective on The Cigna Group from $390.00 to $375.00 and set a "buy" rating for the company in a research report on Tuesday, February 4th. Finally, Raymond James reiterated a "strong-buy" rating and set a $360.00 price objective (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $373.69.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.